Display options
Cite
Zhang HN, Xue JB, Wang AZ, et al. EASINESS: . Front Immunol. 2021;12:747267doi: 10.3389/fimmu.2021.747267.
Zhang, H. N., Xue, J. B., Wang, A. Z., Jiang, H. W., Merugu, S. B., Li, D. W., & Tao, S. C. (2021). EASINESS: . Frontiers in immunology, 12747267. https://doi.org/10.3389/fimmu.2021.747267
Zhang, Hai-Nan, et al. "EASINESS: ." Frontiers in immunology vol. 12 (2021): 747267. doi: https://doi.org/10.3389/fimmu.2021.747267
Zhang HN, Xue JB, Wang AZ, Jiang HW, Merugu SB, Li DW, Tao SC. EASINESS: . Front Immunol. 2021 Dec 03;12:747267. doi: 10.3389/fimmu.2021.747267. eCollection 2021. PMID: 34925322; PMCID: PMC8677947.
Copy Download .nbib Format: NLM
Share it on

Front Immunol. 2021 Dec 03;12:747267. doi: 10.3389/fimmu.2021.747267. eCollection 2021.

EASINESS: .

Frontiers in immunology

Hai-Nan Zhang, Jun-Biao Xue, Aru Ze-Ling Wang, He-Wei Jiang, Siva Bhararth Merugu, Da-Wei Li, Sheng-Ce Tao

Affiliations

  1. Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
  2. Engineering Research Center of Cell and Therapeutic Antibody of Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.

PMID: 34925322 PMCID: PMC8677947 DOI: 10.3389/fimmu.2021.747267

Abstract

Antibodies are one of the most important groups of biomolecules for both clinical and basic research and have been developed as potential therapeutics. Affinity is the key feature for biological activity and clinical efficacy of an antibody, especially of therapeutic antibodies, and thus antibody affinity improvement is indispensable and still remains challenging. To address this issue, we developed the

Copyright © 2021 Zhang, Xue, Wang, Jiang, Merugu, Li and Tao.

Keywords: 18A4Hu; antibody affinity improvement; directed evolution; error-prone DNA polymerase I; protein-fragment complementation assay

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publication Types